Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monocarboxylate transporter 12 (SLC16A12) is a multi-pass transmembrane protein of the solute carrier 16 (SLC16) family, containing 12 transmembrane helices, which mediates the facilitated diffusion of creatine and guanidinoacetate across cellular membranes, independent of sodium, chloride, or pH gradients[1][5][10]. It is highly expressed in tissues including the kidney and ocular lens, where it plays a critical role in creatine homeostasis and energy metabolism[5][12][15]. Loss-of-function mutations in SLC16A12 are associated with a syndromic presentation comprising juvenile cataracts, microcornea, and renal glucosuria, while recent evidence implicates impaired creatine or guanidinoacetate transport as a mechanism underlying disease pathology[5][7][13]. Though most disease associations are monogenic and rare, broader implications in cancer or common metabolic diseases are considered for SLC16 family members but not yet established for SLC16A12[3][4][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monocarboxylate transporter 12 (SLC16A12).